Marsh McLennan Q1 2023: revenue $5.9B (+7%), adj. EPS $2.53 (+10%)

MARSH & MCLENNAN COMPANIES, INC.

2023-Q1 EPS reported $2.47 revenue$5,924,000,000

GAAP revenue $5.9B, +7% YoY; underlying revenue +9%; operating income $1.7B, +19%.
GAAP EPS $2.47 (+18%); adjusted EPS $2.53 (+10%) vs $2.30 year ago.
Risk & Insurance Services revenue $3.9B (+10%); underlying +11%; Marsh underlying +9%.
Consulting revenue $2.0B (+1%); underlying +5%; Mercer underlying +7%, Oliver Wyman flat.
Repurchased 1.8M shares for $300M; issued $600M 30-yr senior notes in Q1.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

MARSH & MCLENNAN COMPANIES, INC. reported first quarter ended March 31, 2023 results: revenue $5.9 billion, net income $1.2 billion, EPS $2.47 per diluted share.

Period: first quarter ended March 31, 2023
Revenue: $5.9 billion
Net income: $1.2 billion
EPS: $2.47 per diluted share
Result: reported results

Exact text from the filing

Consolidated revenue in the first quarter of 2023 was $5.9 billion, an increase of 7% compared with the first quarter of 2022. On an underlying basis, revenue increased 9%. Operating income was $1.7 billion, an increase of 19% from the prior year. Adjusted operating income, which excludes noteworthy items as presented in the attached supplemental schedules, rose 13% to $1.8 billion. Net income attributable to the Company was $1.2 billion, or $2.47 per diluted share, compared with $2.10 in the first quarter of 2022. Adjusted earnings per share rose 10% to $2.53 per diluted share compared with $2.30 a year ago.

View on SEC.gov

Browse all earnings releases →

MARSH & MCLENNAN COMPANIES, INC. filing history →

Source: SEC EDGAR

accession 0000062709-23-000033

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.